News

1722 news items

Research

SAPPHIRE trial starts at I-Motion

On 30/11/2022

The SAPPHIRE trial is an international, randomised, double-blind, placebo-controlled phase III trial that will evaluate the effects of a dual treatment : apitegromab (an anti-myostatin…